Michael LaFontaine
- Molecular Biology
- Physiology
- Cellular and Molecular Neuroscience
- Organic Chemistry
- Toxicology top 10%
- Co-authors
- D. Allan ButterfieldBeverly J. HowardMark P. MattsonC. Roy D. LancasterM. Gregor MadejJan W. BatsHarald SchwalbeAmit S. Kalgutkar
- Topics
- Mitochondrial Function and Pathology (3 papers)Mesenchymal stem cell research (2 papers)Eicosanoids and Hypertension Pharmacology (2 papers)
- Journals
- Journal of Medicinal ChemistryMethods in enzymology on CD-ROM/Methods in enzymologyCurrent Medicinal Chemistry
- Partner nations
- United StatesGermany
In The Last Decade
Michael LaFontaine
11 papers receiving 239 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 97
- Physiology 71
- Cellular and Molecular Neuroscience 47
- Organic Chemistry 40
- Toxicology 34
Countries citing papers authored by Michael LaFontaine
This map shows the geographic impact of Michael LaFontaine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael LaFontaine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael LaFontaine more than expected).
Fields of papers citing papers by Michael LaFontaine
This network shows the impact of papers produced by Michael LaFontaine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael LaFontaine. The network helps show where Michael LaFontaine may publish in the future.
Co-authorship network of co-authors of Michael LaFontaine
This figure shows the co-authorship network connecting the top 25 collaborators of Michael LaFontaine. A scholar is included among the top collaborators of Michael LaFontaine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael LaFontaine. Michael LaFontaine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 48 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 18 | |
| 9 | 16 | |
| 10 | 29 | |
| 11 | 107 |
About Michael LaFontaine
Michael LaFontaine is a scholar working on Biochemistry, Biological Psychiatry and Transplantation, having authored 11 papers that have together received 243 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (3 papers), Mesenchymal stem cell research (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Toxicology (34 citations), Biological Psychiatry (12 citations) and Neurology (25 citations). Michael LaFontaine has collaborated with scholars based in United States and Germany. Frequent co-authors include D. Allan Butterfield, Beverly J. Howard, D. Allan Butterfield, Mark P. Mattson, C. Roy D. Lancaster, M. Gregor Madej, Jan W. Bats, Harald Schwalbe, Amit S. Kalgutkar and Robin Panisch. Their work appears in journals such as Journal of Medicinal Chemistry, Methods in enzymology on CD-ROM/Methods in enzymology and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.